Eli Lilly and Company(LLY)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
LLY | 1.06 T | 40.23x | 47.70% | 33.53% | $29.55 | 102.29% | 1.62x | 0.56% | $1292.65 | $783.85 |
JNJ | 622.84 B | 30.66x | 6.60% | 21.48% | $8.43 | 25.74% | 0.58x | 2.03% | $281.07 | $178.91 |
MRK | 352.29 B | 115.15x | 5.10% | 4.77% | $1.24 | 6.96% | 1.28x | 2.31% | $156.00 | $79.67 |
PFE | 159.59 B | 37.33x | 2.60% | 6.80% | $0.75 | 5.01% | 0.74x | 6.12% | $29.21 | $22.57 |
BMY | 121.95 B | 13.36x | 5.70% | 18.87% | $4.47 | 46.60% | 2.02x | 4.08% | $68.64 | $41.13 |
Peer Valuation & Performance Analysis
Peer group analysis for Eli Lilly and Company (LLY) compared to its primary competitors (including JNJ, MRK, PFE) reveals distinct metrics. LLY trades at a valuation discount relative to its competitors, with a P/E ratio of 40.2x versus the peer average of 49.1x (representing a 18% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, LLY's revenue growth of 47.7% exceeds the peer average of 5.0%, highlighting its competitive strength and market share gains. Additionally, it boasts superior profitability with a net margin of 33.5% compared to the peer average of 13.0%, demonstrating strong cost controls and pricing power.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• LLY ranks #4 in P/E ratio, #1 in revenue growth, and #1 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-07 | $1173.62 | $1206.63 | $1166.00 | $1188.72 | 2,303,500 | +2.70% |
| 2026-10-06 | $1147.15 | $1177.07 | $1139.98 | $1157.49 | 2,131,000 | +1.26% |
| 2026-10-05 | $1150.76 | $1165.73 | $1139.50 | $1143.12 | 1,976,600 | +0.02% |
| 2026-10-02 | $1153.82 | $1164.92 | $1136.66 | $1142.85 | 2,052,300 | -0.61% |
| 2026-10-01 | $1155.00 | $1158.72 | $1139.85 | $1149.85 | 2,172,500 | -0.62% |
| 2026-09-30 | $1186.49 | $1215.00 | $1155.27 | $1157.08 | 3,407,700 | -2.33% |
| 2026-09-29 | $1186.05 | $1192.94 | $1168.47 | $1184.63 | 1,658,100 | -0.01% |
| 2026-09-28 | $1180.30 | $1194.09 | $1172.56 | $1184.78 | 1,971,200 | +0.11% |
| 2026-09-25 | $1185.32 | $1190.00 | $1160.84 | $1183.46 | 1,923,200 | +0.13% |
| 2026-09-24 | $1156.67 | $1197.79 | $1151.00 | $1181.89 | 2,417,700 | +2.68% |
| 2026-09-23 | $1174.71 | $1188.88 | $1145.98 | $1150.99 | 2,154,100 | -1.64% |
| 2026-09-22 | $1146.15 | $1180.53 | $1139.26 | $1170.14 | 2,453,100 | +0.45% |
| 2026-09-21 | $1144.50 | $1170.90 | $1134.41 | $1164.89 | 2,476,600 | +1.04% |
| 2026-09-18 | $1150.00 | $1157.60 | $1140.27 | $1152.93 | 4,542,600 | +0.04% |
| 2026-09-17 | $1150.27 | $1159.75 | $1138.26 | $1152.44 | 1,896,400 | +1.28% |
Explore More Analysis for LLY
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.